BPC-157 (Body Protective Compound 157) is a synthetic pentadecapeptide — a 15 amino acid sequence derived from a protein found in human gastric juice. It has been the subject of extensive pre-clinical research, particularly in the areas of tissue repair and healing.
Australian researchers studying BPC-157 have focused on its remarkable regenerative properties across multiple tissue types, including muscle, tendon, ligament, bone and neural tissue.
BMPeptides supplies research-grade BPC-157 to researchers across Australia, including Sydney, Melbourne, Brisbane, Perth and Adelaide, with full HPLC verification and certificates of analysis available on request.
Pre-clinical studies on BPC-157 have examined a wide range of biological mechanisms. The compound appears to work through multiple pathways simultaneously, which has made it a subject of considerable interest in the research community.
Studies have examined BPC-157 effects on tendon-to-bone healing, muscle repair after crush injury, and ligament reconstruction in animal models.
Pre-clinical research has explored BPC-157 effects on dopamine system modulation and potential neuroprotective properties.
As a gastric peptide derivative, BPC-157 has been extensively studied for GI tract healing, including ulcer models and inflammatory bowel models.
Research has examined angiogenesis promotion and nitric oxide system interaction in pre-clinical cardiovascular models.
BMPeptides ships BPC-157 to all Australian states and territories including New South Wales, Victoria, Queensland, Western Australia, South Australia, Tasmania, the ACT and the Northern Territory.
All shipments are sent in plain packaging with no product names, company branding or contents description on the outside. Temperature-sensitive items are shipped with appropriate cold chain packaging.
Typical delivery times to major Australian cities: Sydney 3–5 days, Melbourne 3–5 days, Brisbane 4–6 days, Perth 5–8 days, Adelaide 4–6 days.
Your cart is empty